Statistics

Total Visits

Views
Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The24

Select a period of time:

Number of views in the range

Views
Treatment outcomes according to extended RAS mutation testing in a phase II study of first-line mFOLFOX plus cetuximab followed by cetuximab in monotherapy as maintenance therapy or mFOLFOX plus cetuximab in patients with metastatic colorectal cancer: The16

Views

Views
October 20240
November 20240
December 20240
January 20250
February 20251
March 202515
April 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Germany1
 

Top cities views

Views